Preclinical investigations with mistletoe (Viscum album L.) extract Iscador

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 6 A, 2006, Pages 497-507

  Maldacker, Juliane ^a  

^a PAREXEL INTERNATIONAL   (United States)

Author keywords

Iscador ; Mistletoe extract, anti tumor activity, preclinical investigations, toxicological investigations; Viscum album L.

Indexed keywords

VISCUM ALBUM EXTRACT; ANTINEOPLASTIC AGENT; PLANT EXTRACT; VEGETABLE PROTEIN; VISCUM ALBUM PEPTIDE;

ABSENCE OF SIDE EFFECTS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PATIENT; CANCER THERAPY; DRUG MECHANISM; GENOTOXICITY; HUMAN; IN VIVO STUDY; NONHUMAN; TUMOR GROWTH; VISCUM ALBUM; ANIMAL; DRUG EFFECT; DRUG SCREENING; MUTAGEN TESTING; REPRODUCTION; REVIEW; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DRUG EVALUATION, PRECLINICAL; HUMANS; MUTAGENICITY TESTS; PLANT EXTRACTS; PLANT PROTEINS; REPRODUCTION;

EID: 33748665010     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296817     Document Type: Article

References (46)

1. Antony, S., Kuttan, R., Kuttan, G., Effect of viscum album in the inhibition of lung metastasis in mice induced by B16F10 melanoma cells. J. Exp. Clin. Cancer Res. 16, 159 (1997)
2. Antony, S., Kuttan, R., Kuttan, G., Inhibition of lung metastasis by adoptive immunotherapy using Iscador. Immunol. Invest. 28, 1 (1999)
3. Antony, S., Kuttan, R., Kuttan, G., Role of natural killer cells in Iscador mediated inhibition of metastasis by adoptive immunotherapy. Immunol. Invest. 29, 219 (2000)
4. Bantel, E., Breuninger, H., In Vitro Untersuchungen zur Wirkung eines Mistelpraeparats auf Melanomzellen (Effects of mistletoe extracts on melanoma cells in vitro). Z. Hautkrankr. 65, 562 (1990)
5. Berger, M., Schmähl, D., Studies on the tumor-inhibiting efficacy of Iscador in experimental animal tumors. J. Cancer Res. Clin. Oncol. 105, 262 (1983)
6. Bloksma, N., Schmiermann, R, De Reuver, M. et al., Stimulation of humoral and cellular immunity by viscum preparations. Planta Med. 46, 221 (1982)
7. Bocci, V., Mistletoe (Viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy - A review. J. Biol. Regul. Homeost. Agents 7, 1 (1993)
8. Braun, J. M., Ko, H. L., Schierholz, J. M. et al., Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models. Anticancer Res. 22, 4187 (2002)
9. Bussing, A., Schietzel, D., Schietzel, M. et al., Keine Stimulation in-vitro-kultivierter Tumourzellen durch Mistellektin (No stimulation of in vitro cultivated tumor cells by mistletoe leetin). Dtsch. Z. Onkol. 36, 66 (2004)
10. Cicalese, R., Brightwell, J., Iscador M spezial 20%, subcutaneous embryo-foetal development study in rabbits, RTC Study No. 22580, Research Toxicology Centre S.p.A., Rome, Italy (2005)
11. Ciliutti, P., Brightwell, J., Iscador M spezial 20%, Chromosome aberrations in human lymphocytes cultured in vitro. RTC Study No. 31610, Research Toxicology Centre S.p.A., Rome, Italy (2004a)
12. Ciliutti, P., Brightwell, J., Iscador Qu spezial 20%, Chromosome aberrations in human lymphocytes cultured in vitro. RTC Study No. 31620, Research Toxicology Centre S.p.A., Rome, Italy (2004b)
13. Frank, U., Engels, I., Wagner, A. et al., Influence of mistletoe (Viscum album) extracts on phagocytosis/burst activity of human phagocytes. Eur. J. Clin. Microbiol. Infect Dis 22, 501 (2003)
14. Gawlik, C., Versteeg, R., Engel, E. et al. (eds.), Antiproliferative effect of mistletoe-extracts in melanoma cell lines. Fourth International Conference of Anticancer Research, Athens, Greece, Oct 21-25, 1992
15. Ghelman, R., Action of Viscum album on the pregnant albino female rat (Rattus norvegicus albinus, rodentia, mammalia): morphological and radiological study, Theory presented to the Federal University of Sao Paulo - Escola Paulista ded Medicina for obtaining of Doctor's Title in Medicine, Sao Paulo (2003)
16. Gorter, R. W., Joller, P., Stoss, M., Cytokine release of a keratinocyte model after incubation with two different Viscum album L extracts. Am. J. Ther. 10, 40 (2003)
17. Hamprecht, K., Handgretinger, R., Voetsch, W. et al., Mediation of human NK-activity by components in extracts of viscum album. Int. J. Immunopharmacol. 9, 199 (1987)
18. Kauffmann, H. M., Iscador Qu 20%, mammalian erythrocyte micronucleus test in male and female Sprague Dawley rats. Toxicology Study Report No. PT02-0397, ProTox, Hattersheim (2003a)
19. Kauffmann, H. M., Iscador P 20%, mammalian erythrocyte micronucleus test in male and female Sprague Dawley rats. Toxicology Study Report No. PT02-0396, ProTox, Hattersheim (2003b)
20. Kelter, G., Fiebig, H. H., In vitro evaluation of Iscador® M special, Iscador® Qu special and Iscador® P from Weleda AG in a panel of 16 human tumor cell lines. Oncotest GmbH, April 5, 2001a
21. Kelter, G., Fiebig, H. H., In vitro evaluation of Iscador® M special, Iscador® Qu special and Iscador® P from Weleda AG in a panel of 4 hematological human tumor cell lines. Oncotest GmbH, September 14, 2001b
22. Kelter, G., Fiebig, H. H., In vitro evaluation of Iscador® from Weleda AG in 6 human tumor cell lines derived from sarcoma and melanoma. Oncotest GmbH, January 21, 2002
23. Kelter, G., Fiebig, H. H., In vitro evaluation of Iscador® M special, Iscador® Qu special and Iscador® P for anti-cancer activity in a panel of 12 human tumor cell lines in a monolayer proliferation assay. Oncotest GmbH, June 4, 2003
24. Khwaja, T. A., Dias, C. B., Pentecost S. Recent studies on the anticancer activities of mistletoe (Viscum album) and its alkaloids. Oncology 43 (Suppl. 1), 42 (1986)
25. Kienle, G. S., Keine, H., Die Mistel in der Onkologie - Fakten und konzeptionelle Grundlagen - wissenschafliche Ergebnisse und Diskussionen im Kontext moderner Tumourimmunologie, klinischer Methodologie und aktueller Krebskonzepte. Institut für angewandte Erkenntnistheorie und medizinische Methodologie e.V., Bad Krozingen (2002)
26. Kuttan, G., Tumouricidal activity of mouse peritoneal macrophages treated with Viscum album extract. Immunol. Invest. 22, 431 (1993)
27. Kuttan, G., Kuttan, R., Immunological mechanism of action of the tumor reducing peptide from mistletoe extract (NSC 635089) cellular proliferation. Cancer Lett. 66, 123 (1992a)
28. Kuttan, G., Kuttan, R., Immunomodulatory activity of a peptide isolated from Viscum album extract (NSC 635 089). Immunol. Invest. 21, 285 (1992b)
29. Kuttan, G., Menon, L. G., Kuttan, R., Prevention of 20- methylcholanthrene-induced sarcoma by a mistletoe extract, Iscador. Carcinogenesis 17, 1107 (1996)
30. Longobardi, C., Brightwell, J., Iscador M spezial 20%, single dose subcutaneous toxicity study in rats. RTC Study No. 22470, Research Toxicology Centre S.p.A., Rome, Italy (2003)
31. Longobardi, C., Brightwell, J., Iscador Qu spezial 20%, single dose subcutaneous toxicity study in rats. RTC Study No. 21190, Research Toxicology Centre S.p.A., Rome, Italy (2004a)
32. Longobardi, C., Brightwell, J., Iscador P 20%, single dose subcutaneous toxicity study in rats. RTC Study No. 22460, Research Toxicology Centre S.p.A., Rome, Italy (2004b)
33. Mueller, E. A., Hamprecht, K., Anderer, F. A., Biochemical- characterization of a component in extracts of Viscum-album enhancing human nk cyto-toxicity. Immunopharmacology 17, 11 (1989)
34. Pfüller, U., Chemical constituents of European mistletoe (Viscum album L). In: Bussing A, editor. Mistletoe - The Genus Viscum, pp. 101-122, Harwood Academic Publishers, Australia - Canada etc. (2000)
35. Rentea, R., Lyon, E., Hunter, R., Biologic properties of Iscador - A Viscum album preparation - I Hyperplasia of the thymic cortex and accelerated regeneration of hematopoietic cells following X-irradiation. Labor Invest. 44, 43 (1981)
36. Ribéreau-Gayon, G., Jung, M. L., Baudino, S. et al., Effects of mistletoe (Viscum album L) extracts on cultured tumor cells. Experientia 42, 594 (1986a)
37. Ribéreau-Gayon, G., Jung, M. L., Di Scala, D. et al., Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells. Oncology 43 (Suppl. 1), 35 (1986b)
38. Scarcella, O., Brightwell, J., Iscador M spezial 20%, bacterial mutation assay (S. typhimurium and E. coli). RTC Study No. 22490, Research Toxicology Centre S.p.A., Rome, Italy (2004a)
39. Scarcella, O., Brightwell, J., Iscador Qu spezial 20%, bacterial mutation assay (S. typhimurium and E. coli). RTC Study No. 21200, Research Toxicology Centre S.p.A., Rome, Italy (2004b)
40. Scarcella, O., Brightwell, J., Iscador P 20%, bacterial mutation assay (S. typhimurium and E. coli). RTC Study No. 22480, Research Toxicology Centre S.p.A., Rome, Italy (2004c)
41. Stein, G. M., Berg, P. A., Evaluation of the stimulatory activity of a fermented mistletoe lectin-1 free mistletoe extract on T-helper cells and monocytes in healthy individuals in vitro. Arzneim.-Forsch./Drug Res. 46, 635 (1996)
42. Stein, G. M., Berg, P. A., Flow cytometric analyses of the specific activation of peripheral blood mononuclear cells from healthy donors after in vitro stimulation with a fermented mistletoe extract and mistletoe lectins. Eur. J. Cancer 34, 1105 (1998)
43. Stein, G. M., Meink, H., Durst, J. et al., Release of cytokines by a fermented lectin-1 (ML-1) free mistletoe extract reflects differences in the reactivity of PBMC in healthy and allergic individuals and tumor patients. Eur. J. Clin. Pharmacol. 51, 247 (1996)
44. Stein, G. M., Büssing, A., Schietzel, M., Stimulation of the maturation of dendritic cells in vitro by a fermented mistletoe extract. Anticancer Res. 22, 4215 (2002)
45. Van Huyen, J. P. D., Bayry, J., Delignat, S. et al., Induction of apoptosis of endothelial cells by Viscum album - A role for anti-tumoural properties of mistletoe lectins. Mol. Med. 8, 600 (2002)
46. Werner, M., Zaenker, K. S., Nikolai, G., Stimulation of T-cell locomotion in an in-vitro assay by various Viscum album L preparations (Iscador). Int. J. Immunother. 14, 135 (1998)